V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008692 | 190002422 | null | null | null | null | 2017-02-24 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100135356 |
| 190008693 | 190002423 | null | null | null | null | 2017-08-21 | STS Rhabdomyosarcoma RMS 2005 IVADo | null | null | DOXORUBICIN + IFOSFAMIDE | 100593995 |
| 190008698 | 190002425 | 1.76 | 73 | Curative (C) | 2016-12-26 | 2017-01-01 | Cisplatin + Radiotherapy | 02 | N | DOXORUBICIN | 100305349 |
| 190008701 | 190002427 | null | null | null | null | 2020-06-09 | Capecitabine + Oxaliplatin 21day | null | null | CAPECITABINE + CISPLATIN | 101409225 |
| 190008704 | 190002428 | null | null | null | null | 2019-04-12 | Oxaliplatin + Modified de Gramont | null | null | GC INT GUIDE EXCRANIAL GERMCELL JEB | 101445578 |
| 190008708 | 190002429 | null | null | null | null | 2017-12-09 | Capecitabine + Oxaliplatin 21day | null | null | DOXORUBICIN + METHOTREXATE | 100488455 |
| 190008716 | 190002431 | null | null | null | null | 2018-08-06 | EURAMOS TRIAL | null | null | EURO-EWING | 100394790 |
| 190008720 | 190002433 | 1.72 | null | Curative (C) | 2019-02-08 | 2019-02-08 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101803983 |
| 190008724 | 190002434 | 1.83 | 58.2 | Adjuvant (A) | 2019-07-18 | 2019-07-21 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100887889 |
| 190008730 | 190002435 | null | null | null | null | 2017-11-15 | PAM x 2 pre-surgery (cycles 1&2) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101266420 |
| 190008734 | 190002436 | 1.63 | 61.8 | Palliative (P) | 2019-02-12 | 2019-02-12 | GEMCITABINE | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101136109 |
| 190008746 | 190002440 | 1.73 | 59.7 | Palliative (P) | 2020-02-22 | 2020-02-23 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101063936 |
| 190008750 | 190002441 | 1.55 | 75.6 | Curative (C) | 2019-01-26 | 2019-03-03 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 100099973 |
| 190008752 | 190002442 | 1.72 | 57 | Neo-adjuvant (N) | 2016-05-12 | 2016-05-19 | EW EuroEwing 2012 Arm A VIDE | null | null | DOXORUBICIN + IFOSFAMIDE | 100001977 |
| 190008756 | 190002443 | null | null | null | null | 2019-01-20 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100051167 |
| 190008759 | 190002444 | 1.73 | 74.4 | Neo-adjuvant (N) | 2017-06-04 | 2017-07-02 | Doxorubicin 75mg/m2 | 02 | N | TRIAL | 100237059 |
| 190008760 | 190002445 | null | null | null | null | 2018-10-16 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100796517 |
| 190008761 | 190002446 | null | null | null | null | 2020-03-05 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101780788 |
| 190008763 | 190002447 | 0 | 98.1 | Curative (C) | 2019-03-07 | 2019-04-02 | PAM x 2 pre-surgery (cycles 1&2) | null | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101179629 |
| 190008767 | 190002448 | null | null | null | null | 2016-10-07 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100148982 |
| 190008770 | 190002449 | null | null | null | null | 2018-08-23 | Cisplatin + Radiotherapy | null | null | AZACITIDINE | 100692820 |
| 190008772 | 190002450 | 1.77 | 79.9 | null | null | 2017-05-05 | Dox + HD Mtx (post PAM) | null | null | VIDE | 101132865 |
| 190008778 | 190002452 | null | null | null | null | 2016-05-12 | Capecitabine + Oxaliplatin 21day | null | null | NOT MATCHED | 100330975 |
| 190008779 | 190002453 | null | null | null | null | 2017-05-27 | Dox + HD Mtx (post PAM) | null | null | DOXORUBICIN + HD MTX | 100199904 |
| 190008781 | 190002454 | null | null | null | null | 2019-04-04 | CHOP R - 21 days | null | null | DOXORUBICIN | 100245881 |
| 190008784 | 190002455 | null | null | null | null | 2018-03-02 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100997162 |
| 190008786 | 190002456 | 1.78 | 51 | Curative (C) | 2018-11-09 | 2018-11-09 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 100012646 |
| 190008787 | 190002457 | 0 | 79.8 | null | 2017-02-06 | 2017-02-25 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 101771553 |
| 190008789 | 190002459 | 0 | 0 | Adjuvant (A) | 2016-03-26 | 2016-04-05 | FLUOROURACIL + OXALIPLATIN | 02 | N | EW EUROEWING 2012 ARM A VIDE | 101074975 |
| 190008790 | 190002460 | 1.83 | 79.15 | Curative (C) | 2018-06-03 | 2018-06-03 | EW EuroEwing 2012 Arm B VDC | Y | N | EW EUROEWING 2012 ARM B VDC | 100504781 |
| 190008793 | 190002461 | 1.85 | 58.6 | Curative (C) | 2018-03-22 | 2018-04-12 | EW EuroEwing 2012 Arm B VDC | 02 | Y | EW EUROEWING 2012 ARM B VDC | 101271925 |
| 190008796 | 190002462 | 1.81 | 65.6 | Curative (C) | 2017-03-13 | 2017-03-25 | Dox + HD Mtx (post PAM) | 2 | N | DOXORUBICIN + HD MTX | 100923689 |
| 190008798 | 190002464 | null | null | null | null | 2015-11-05 | Gemcitabine weekly | null | null | LANREOTIDE | 101760477 |
| 190008801 | 190002466 | null | null | null | null | 2016-07-23 | Docetaxel 75mg/m2 (21 day) | null | null | CISPLATIN | 100464005 |
| 190008807 | 190002468 | null | null | null | null | 2019-09-23 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN | 100749107 |
| 190008809 | 190002470 | 1.5 | 1.8 | Palliative (P) | 2018-05-31 | 2018-06-19 | GEMCITABINE | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101114688 |
| 190008810 | 190002471 | null | null | null | null | 2019-08-13 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100232815 |
| 190008811 | 190002472 | 1.72 | 74.4 | Adjuvant (A) | 2019-12-19 | 2019-12-26 | OST Euramos 1 Closed Trial - AP | 01 | null | OST AP | 100062786 |
| 190008821 | 190002477 | null | null | null | null | 2018-08-22 | Carboplatin AUC 2 - 5 | null | null | EURO-EWING | 100808096 |
| 190008834 | 190002480 | null | null | null | null | 2016-02-29 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101678873 |
| 190008835 | 190002481 | 1.64 | 84 | null | 2017-01-30 | 2017-01-31 | EOX | N | Y | EURAMOS TRIAL | 101628060 |
| 190008836 | 190002482 | null | null | null | null | 2017-06-02 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100958652 |
| 190008837 | 190002483 | null | null | null | null | 2016-09-08 | Cisplatin + Radiotherapy | null | null | VIDE | 100762711 |
| 190008838 | 190002484 | 1.81 | 75.1 | Curative (C) | 2016-07-22 | 2016-07-28 | LANREOTIDE | 02 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100110176 |
| 190008841 | 190002485 | null | null | null | null | 2019-08-03 | ECX | null | null | GC INT GUIDE EXCRANIAL GERMCELL JEB | 101438254 |
| 190008842 | 190002486 | 1.72 | 77.8 | Curative (C) | 2015-11-06 | 2015-11-07 | Trial Unspecified | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101185084 |
| 190008845 | 190002487 | null | null | null | null | 2017-05-13 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100927741 |
| 190008846 | 190002488 | 0 | 0 | Curative (C) | 2016-04-05 | 2016-04-10 | Cisplatin 100 + RT(H&N) 1 day | N | N | EW EUROEWING 2012 ARM A VIDE | 101420858 |
| 190008852 | 190002489 | null | null | null | null | 2018-03-09 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100662846 |
| 190008855 | 190002490 | 0 | 48.6 | Curative (C) | 2018-06-25 | 2018-06-26 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101595057 |